← Eichor
Study identifier: NCT05197309 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Metabolic Diet for Relapse Prevention in Anorexia Nervosa

Condition: Anorexia Nervosa  ·  Sponsor: Icahn School of Medicine at Mount Sinai

PhaseNA
Planned participants20
Who can joinFemale, 18 Years to 40 Years
Healthy volunteersYes

About this study

This is an interventional study that will test the safety, tolerability, and efficacy of the Metabolic Diet, which was designed as a treatment for women with anorexia nervosa to remain weight-stable after they have been restored from low weight. Participants will be adult women with anorexia nervosa who have been recently restored to normal weight and adult women with no history of eating disorders. After enrollment, participants will start meeting weekly with a registered dietitian to implement the Metabolic Diet in their daily lives, and will receive medical monitoring for adherence, side effects, changes in metabolic or psychological parameters, and weight stability.

This description comes directly from the study's public registry record.

Talk to the study team

Chinara Tate  ·  (212) 659-8724  ·  chinara.tate@mssm.edu

Tom Hildebrandt  ·  212-659-8673  ·  tom.hildebrandt@mssm.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Icahn School of Medicine at Mount SinaiNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05197309